Skip to content
Subscriber Only

These New Drugs Could Cut Heart Risks in Half

Video player cover image

Will These Drugs Reduce Your Risk of Heart Disease?

New drugs by Amgen Inc., Sanofi and Regeneron Pharmaceuticals Inc. for treating heart disease, the world’s No. 1 killer, are showing signs that they can reduce cardiovascular complications as they lower cholesterol levels.

Repatha, made by Amgen, and Praluent, under development by Sanofi and Regeneron, both cut cholesterol levels by more than 60 percent in studies published Sunday in the New England Journal of Medicine. The trials also showed patients getting the injected drugs were half as likely to die or suffer a major cardiac complication, such as a heart attack, stroke or chest pain, after just a year to 18 months of treatment.